National Comprehensive Cancer Network

Educational Events & Programs

NCCN Clinical Practice Guidelines in Oncology Symposium™ Colon and Rectal Cancers

Friday, November 06, 2009 (Baltimore, MD)
8:00 AM – 12:00 PM

Program Location:
Sheraton Baltimore City Center Hotel
101 West Fayette Street
Baltimore, MD
(Directions)

Register now to secure a seat at this educational activity.

Program Overview:
NCCN, drawing on the expertise of faculty from its 21 Member Institutions, has developed and maintains clinical practice guidelines addressing colon and rectal cancers as part of its complete library of NCCN Clinical Practice Guidelines in Oncology™.

The NCCN Colon and Rectal Cancers Guidelines provide sequential recommendations for the management of lower G.I. malignancies. The symposium topics include surgical approaches to colorectal cancers, adjuvant therapy for locoregional rectal cancer, therapy for advanced disease and a review of ongoing studies, and the NCCN Outcomes Database: Colorectal Cancer.

Using the NCCN Guidelines as a resource, this half-day program will address the topics listed above and feature interactive audience participation via case scenarios. An audience response system will be utilized to illustrate the application of the guidelines and the rationales for specific recommendations.

Educational Objectives:
Following this program, participants should be able to:

• Describe the role of NCCN colon and rectal cancers outcomes database in benchmarking quality of care;
• List the different surgical approaches to management of colon cancer based on site and stage at presentation;
• Define rectal cancer and describe surgical treatment options available;
• State the role of pre- and postoperative radiation in combination with chemotherapy in the management of rectal cancer;
• Summarize the principles of pre and post-operative therapy for rectal cancer as described in the NCCN Clinical Practice Guidelines in Oncology™
• Describe the chemotherapies available for metastatic colon cancer as stated in the NCCN Clinical Practice Guidelines in Oncology™;
• Summarize data presented regarding ongoing trials in metastatic colorectal cancer.

Intended Audience:
This educational program is designed to meet the needs of oncologists, nurses, pharmacists, and other healthcare professionals who manage patients with cancer.

Agenda:

Accreditation:
Physicians
The National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NCCN designates this educational activity for a maximum of 3.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Nurses
This activity is approved for 3.2 contact hours. National Comprehensive Cancer Network is an approved provider of continuing nursing education by PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

Approval as a provider refers to recognition of educational activities only and does not imply ANCC Commission on Accreditation or PA Nurses approval or endorsement of any product.

Kristina M. Gregory, RN, MSN, OCN, is our nurse planner for this educational activity.

Pharmacists

Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

This program is acceptable for 3.25 hours (.325 CEUs) of continuing education credit in states that recognize ACPE-accredited providers.

The Postgraduate Institute for Medicine designates this continuing education activity for 3.25 contact hour(s) (0.325 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number 809-999-09-074-L01-P)

Fee Information
There is no fee for this educational activity. In order to receive a statement of credit, participants will need to attend the educational activity and complete the evaluation form. Partial credit will not be awarded. Statements of credit will be mailed within 4 to 6 weeks of the meeting. Pharmacists should note that they must attend the entire activity to be eligible for credit.

This is a knowledge-based educational activity.

Faculty Disclosure
All faculty participating in NCCN continuing education activities are expected to disclose any conflict(s) of interest related to the content of their presentation(s) as defined by the ACCME’s and ANCC’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2 and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

Hosted By:
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Supporters:
Supported by educational grants from Amgen, Bristol-Myers Squibb Company and ImClone Systems Incorporated, Genentech BioOncology, Pfizer Inc., and sanofi-aventis, U.S.

Registration Information:
Registration fees are:

If cancellation is necessary, please notify NCCN. A substitute attendee may be sent in your place. Registration fees are non-refundable.

Register now to secure a seat at this educational activity.